0
0

Department of Veterans Affairs Awarded a Contract to TRAVERE THERAPEUTICS, INC. for $33,371.51

Signed on

5/7/2026, 12:00 AM

TRAVERE THERAPEUTICS, INC. Government Contract #36C24526N0571

TRAVERE THERAPEUTICS, INC. was awarded a contract with the United States Government for $33,371.51. The contract was awarded by the agency office 245-NETWORK CONTRACT OFFICE 5 (36C245), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Traveré Therapeutics, Inc., a small U.S.-owned business in San Diego, California, specializing in pharmaceutical preparation manufacturing. The contract is for patient medication order of Thiola 100mg for the Clarksburg VA Medical Center Pharmacy, funded by the Department of Veterans Affairs, with a total obligation of $33,371.51. The notable transaction is the delivery order issued on 2026-05-07 for the specified medication.

Contract Details

Contract ID36C24526N0571
Contract TypeC
Total Obligation$33,371.51
Exercised Options$33,371.51
Base Amount + Options$33,371.51
Date Signed2026-05-07
Contract DescriptionPATIENT MEDICATION ORDER OF THIOLA 100MG FOR THE CLARKSBURG VA MEDICAL CENTER PHARMACY.
Start Date2026-05-07
End Date2026-05-14

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding Office245-NETWORK CONTRACT OFFICE 5 (36C245)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding Office540-CLARKSBURG (00540)(36C540)

Recipient Details

RecipientTRAVERE THERAPEUTICS, INC.
Recipient Location3611 VALLEY CENTRE DR STE 300 SAN DIEGO CALIFORNIA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0$33,371.51May 7, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $33,371.51 to TRAVERE THERAPEUTICS, INC.. The payment included a Subsidy Cost of $0.00.